LESLIE NORMAN: Open Payments
NPI 1215234505 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 14 payments from 8 companies in 2025. Trend: 2023 $728 · 2024 $615 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Myriad Genetic Laboratories, Inc. | 2 | $36 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $19 |
| Celgene Corporation | 1 | $19 |
Products named: Trodelvy, Enhertu, KEYTRUDA, MYRISK, DATROWAY, Orserdu, PLASMABLADE(TM), IMFINZI.
Industry payments across TN — which companies pay providers there.
